Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:2501-2504

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishibashi, Y.
Right arrow Articles by Takeshita, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishibashi, Y.
Right arrow Articles by Takeshita, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL

(Circulation. 1997;96:2501-2504.)
© 1997 American Heart Association, Inc.


Articles

Negative Inotropic Effect of Basic Fibroblast Growth Factor on Adult Rat Cardiac Myocyte

Yuji Ishibashi, MD; Yoshitoshi Urabe, MD; Hiroyuki Tsutsui, MD; Shintaro Kinugawa, MD; Masaru Sugimachi, MD; Masaru Takahashi, MD; Shimako Yamamoto, MD; Hirofumi Tagawa, MD; Kenji Sunagawa, MD; ; Akira Takeshita, MD

From the Research Institute of Angiocardiology and Cardiovascular Clinic, Kyushu University School of Medicine (Y.I., Y.U., H. Tsutsui, S.K., M.T., S.Y., H. Tagawa, A.T.), Fukuoka, and Department of Cardiovascular Dynamics, National Cardiovascular Center (M.S., K.S.), Suita, Osaka, Japan.

Correspondence to Hiroyuki Tsutsui, MD, PhD, Research Institute of Angiocardiology and Cardiovascular Clinic, Kyushu University School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-82, Japan.

Background Basic fibroblast growth factor (bFGF) is highly expressed in the myocardium in some cardiac disorders, such as ischemia-reperfusion and cardiac allograft rejection. However, whether bFGF has any effects on myocardial contraction is unknown.

Methods and Results We examined the effects of bFGF on myocardial contractility using isolated adult rat cardiac myocyte preparations. bFGF exerted a direct negative inotropic effect that was concentration and time dependent. The pretreatment of myocytes with a neutralizing anti-bFGF antibody (100 ng/mL) abolished the negative inotropic effects of bFGF (100 ng/mL). Platelet-derived growth factor (12.5 ng/mL) and transforming growth factor-ß (1 ng/mL) did not exert such effects, which indicated that bFGF-induced negative inotropism was considered to be specific for this growth factor. bFGF decreased the peak intracellular Ca2+ transient by 46% during systole. The enhanced production of nitric oxide was unlikely to be responsible for the bFGF-induced negative inotropic effect.

Conclusions bFGF, primarily a potent growth promoter, produced acute negative inotropic effects in the adult cardiac myocyte that could have resulted from alterations in intracellular Ca2+ homeostasis. The negative inotropic effect of bFGF may contribute to myocardial dysfunction associated with ischemia-reperfusion injury and heart transplant rejection.


Key Words: growth substances • cells • muscles • contractility • calcium




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. K. Sen, S. Khanna, and S. Roy
Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart
Cardiovasc Res, July 15, 2006; 71(2): 280 - 288.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. L. House, C. Bolte, M. Zhou, T. Doetschman, R. Klevitsky, G. Newman, and J. E. J. Schultz
Cardiac-Specific Overexpression of Fibroblast Growth Factor-2 Protects Against Myocardial Dysfunction and Infarction in a Murine Model of Low-Flow Ischemia
Circulation, December 23, 2003; 108(25): 3140 - 3148.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. A. Detillieux, F. Sheikh, E. Kardami, and P. A. Cattini
Biological activities of fibroblast growth factor-2 in the adult myocardium
Cardiovasc Res, January 1, 2003; 57(1): 8 - 19.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. G. Hampton, I. Amende, J. Fong, V. E. Laubach, J. Li, C. Metais, and M. Simons
Basic FGF reduces stunning via a NOS2-dependent pathway in coronary-perfused mouse hearts
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H260 - H268.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Kinugawa, H. Tsutsui, S. Satoh, M. Takahashi, T. Ide, K. Igarashi-Saito, K.-i. Arimura, K. Egashira, and A. Takeshita
Role of Ca2+ availability to myofilaments and their sensitivity to Ca2+ in myocyte contractile dysfunction in heart failure
Cardiovasc Res, November 1, 1999; 44(2): 398 - 406.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Kinugawa, H. Tsutsui, T. Ide, R. Nakamura, K.-i. Arimura, K. Egashira, and A. Takeshita
Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes
Cardiovasc Res, July 1, 1999; 43(1): 157 - 164.
[Abstract] [Full Text] [PDF]